168 related articles for article (PubMed ID: 10574507)
1. Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator.
Rocchi S; Auwerx J
Ann Med; 1999 Oct; 31(5):342-51. PubMed ID: 10574507
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma, the ultimate liaison between fat and transcription.
Rocchi S; Auwerx J
Br J Nutr; 2000 Dec; 84 Suppl 2():S223-7. PubMed ID: 11242474
[TBL] [Abstract][Full Text] [Related]
3. The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity.
Celi FS; Shuldiner AR
Curr Diab Rep; 2002 Apr; 2(2):179-85. PubMed ID: 12643137
[TBL] [Abstract][Full Text] [Related]
4. PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes.
Pelton PD; Zhou L; Demarest KT; Burris TP
Biochem Biophys Res Commun; 1999 Aug; 261(2):456-8. PubMed ID: 10425206
[TBL] [Abstract][Full Text] [Related]
5. Abietic acid activates peroxisome proliferator-activated receptor-gamma (PPARgamma) in RAW264.7 macrophages and 3T3-L1 adipocytes to regulate gene expression involved in inflammation and lipid metabolism.
Takahashi N; Kawada T; Goto T; Kim CS; Taimatsu A; Egawa K; Yamamoto T; Jisaka M; Nishimura K; Yokota K; Yu R; Fushiki T
FEBS Lett; 2003 Aug; 550(1-3):190-4. PubMed ID: 12935909
[TBL] [Abstract][Full Text] [Related]
6. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
7. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
Sinha D; Addya S; Murer E; Boden G
Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.
Plutzky J
Curr Atheroscler Rep; 2000 Jul; 2(4):327-35. PubMed ID: 11122762
[TBL] [Abstract][Full Text] [Related]
9. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
Krey G; Braissant O; L'Horset F; Kalkhoven E; Perroud M; Parker MG; Wahli W
Mol Endocrinol; 1997 Jun; 11(6):779-91. PubMed ID: 9171241
[TBL] [Abstract][Full Text] [Related]
10. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells.
Iijima K; Yoshizumi M; Ako J; Eto M; Kim S; Hashimoto M; Sugimoto N; Liang YQ; Sudoh N; Toba K; Ouchi Y
Biochem Biophys Res Commun; 1998 Jun; 247(2):353-6. PubMed ID: 9642130
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
[TBL] [Abstract][Full Text] [Related]
12. PPAR gamma: an essential role in metabolic control.
Fajas L; Debril MB; Auwerx J
Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):64-9. PubMed ID: 11383325
[TBL] [Abstract][Full Text] [Related]
13. Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones.
Bedoucha M; Atzpodien E; Boelsterli UA
J Hepatol; 2001 Jul; 35(1):17-23. PubMed ID: 11495036
[TBL] [Abstract][Full Text] [Related]
14. The pleiotropic functions of peroxisome proliferator-activated receptor gamma.
Debril MB; Renaud JP; Fajas L; Auwerx J
J Mol Med (Berl); 2001; 79(1):30-47. PubMed ID: 11327101
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptors: from genes to physiology.
Kliewer SA; Xu HE; Lambert MH; Willson TM
Recent Prog Horm Res; 2001; 56():239-63. PubMed ID: 11237216
[TBL] [Abstract][Full Text] [Related]
16. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin.
Werman A; Hollenberg A; Solanes G; Bjorbaek C; Vidal-Puig AJ; Flier JS
J Biol Chem; 1997 Aug; 272(32):20230-5. PubMed ID: 9242701
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
Cheng J; Nakamura H; Imanishi H; Liu W; Morisaki T; Sugiyama T; Hada T
Biochem Biophys Res Commun; 2004 Sep; 322(2):458-64. PubMed ID: 15325252
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis.
Masugi J; Tamori Y; Mori H; Koike T; Kasuga M
Biochem Biophys Res Commun; 2000 Feb; 268(1):178-82. PubMed ID: 10652233
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review.
Houseknecht KL; Cole BM; Steele PJ
Domest Anim Endocrinol; 2002 Mar; 22(1):1-23. PubMed ID: 11900961
[TBL] [Abstract][Full Text] [Related]
20. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
